Myriam Abioui-Mourgues

Myriam Abioui-Mourgues

Auto-generated profile, based on publicly available information

Myriam Abioui-Mourgues

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institute Blood and Brain @ Caen-Normandie, UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND); Caen, FRANCE

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2023 in Biomaterials
Verified
Journal Article
Open access
LFLouise Fournier
Louise Fournier
MAMyriam Abioui-Mourgues
Myriam Abioui-Mourgues
GCGeorges Chabouh
Georges Chabouh
RARachida Aid
Rachida Aid
TTThibault De La Taille
Thibault De La Taille
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre
Systemic injection of thrombolytic drugs is the gold standard treatment for non-invasive blood clot resolution. The most serious risks associated with the intravenous injection of tissue plasminogen activator-like proteins are the bleeding complication and the dose related neurotoxicity. Indeed, the drug has to be injected in high concentrations due to its short half-life, the presence of its natural blood inhibitor (PAI-1) and the fast hepatic clearance (0.9 mg/kg in humans, 10 mg/kg in mouse models). Overall, there is a serious need for a dose-reduced targeted treatment to overcome these issues. We present in this article a new acoustic cavitation-based method for polymer MBs synthesis, three times faster than current hydrodynamic-cavitation method. The generated MBs are ultrasound responsive, stable and biocompatible. Their functionalization enabled the efficient and targeted treatment of stroke, without side effects. The stabilizing shell of the MBs is composed of Poly-Isobutyl Cyanoacrylate (PIBCA), copolymerized with fucoidan. Widely studied for its targeting properties, fucoidan exhibit a nanomolar affinity for activated endothelium and activated platelets (P-selectins). Secondly, the thrombolytic agent (rtPA) was loaded onto microbubbles (MBs) with a simple adsorption protocol. Hence, the present study validated the in vivo efficiency of rtPA-loaded Fuco MBs to be over 50 % more efficient than regular free rtPA injection for stroke resolution. In addition, the relative injected rtPA grafted onto targeting MBs was 1/10th of the standard effective dose (1 mg/kg in mouse). As a result, no hemorrhagic event, BBB leakage nor unexpected tissue distribution were observed.

6 June 2025 in Communications Engineering
Verified
Journal Article
Open access
PDF file
GCGeorges Chabouh
Georges Chabouh
LDLouise Denis
Louise Denis
MAMyriam Abioui-Mourgues
Myriam Abioui-Mourgues
JDJean-Baptiste Deloges
Jean-Baptiste Deloges
JBJacques Battaglia
Jacques Battaglia
OCOlivier Couture
Olivier Couture
We present an open-source code for 3D super-resolution ultrasound imaging. Open-3DULM was applied to transcranial imaging in habituated awake mice. Comparative analysis reveals that isoflurane anesthesia induces significant vasodilation and increased cerebral blood flow (CBF) in veins, while only a subset of arteries exhibits these effects compared to the awake state. This method could serve as a reference for developing new types of 3D vascular quantifications, particularly emphasizing the importance of awake and 3D imaging for accurate cerebral blood flow measurement in neuroscience research.

1 January 2026 in Stroke
Verified
Journal Article
Closed access
MAMyriam Abioui-Mourgues
Myriam Abioui-Mourgues
ABAmandine Elodie Bonnet
Amandine Elodie Bonnet
CLCanelle C.M. Lepillier
Canelle C.M. Lepillier
CBCamille Brodin
Camille Brodin
SDSamuel Diebolt
Samuel Diebolt
COCyrille Orset
Cyrille Orset
BACKGROUND: Acute ischemic stroke models often rely on anesthesia, which alters neurovascular coupling and limits real-time functional assessment. We tested the hypothesis that an awake mouse model of thromboembolic stroke, combined with multimodal imaging, would reveal very early cerebrovascular dynamics and connectivity changes predictive of final lesion outcomes. METHODS: Male Swiss mice (6–8 weeks old; 30–40 g; n=60) were implanted with a cranial headplate and habituated to restraint and imaging. One microliter pneumatic injection of murine thrombin (1 IU) into the distal middle cerebral artery induced in situ clot formation. Twenty minutes postocclusion, mice received intravenous rtPA (recombinant tissue-type plasminogen activator; Alteplase, 10 mg/kg; 10% bolus/90% infusion over 40 minutes, n=31) or saline (n=29). Primary outcomes included lesion volume (T2-weighted magnetic resonance imaging at 24 hours), brain perfusion (ASL magnetic resonance imaging), cerebral blood volume variations (ultrafast Doppler US imaging), resting-state connectivity, and neurovascular coupling to whisker stimulation (functional ultrasound imaging). Sample size (n=12 per group for imaging) was based on prior variability. Statistical analyses included unpaired t tests, repeated-measures ANOVA with Dunnett or Tukey post hoc, and simple linear regression; significance set at P <0.05. RESULTS: At 24 hours, rtPA reduced lesion volumes by 36.7% (10.97±4.7 versus 17.33±5.92 mm 3 in controls; t 58 =4.624; P <0.0001). ASL magnetic resonance imaging revealed a 66.5±9.9% CBF drop at 1 hour (F=48.63; P <0.0001) and a 51.2±45.1% hyperperfusion at 24 hours compared with baseline (F=11.67; P =0.0024). CBV declined by 59.2±12.9% at 10 minutes and partially recovered with rtPA at 1 hour (+87.3±30.6%; P =0.0165). Early hypoperfused area (10 minutes) predicted final lesion observed at 24 hours ( R ²=0.6465; P =0.0016). Resting-state connectivity shift of 12.0° at 10 minutes was mitigated by rtPA by 1 hour (14.8° versus 3.6°; P <0.01). Whisker-evoked CBV responses were abolished ipsilaterally at 10 minutes (−100.5±3.3%; P =0.0038) and showed partial recovery by 24 hours with rtPA (+37.2% relative to 10 minutes). At this time point, responses no longer differed significantly from baseline ( P =0.093), indicating a modest but functionally meaningful recovery despite marked interindividual variability. CONCLUSIONS: Awake thromboembolic stroke model with early functional ultrasound imaging completed with magnetic resonance imaging uncovers rapid blood flow perturbations and connectivity disruptions that are sensitive to rtPA and predictive of final lesion outcome. This platform enhances translational relevance by enabling hypothesis-testing of novel thrombolytics under physiologically intact conditions.

1 January 2026 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
NBNakougou Moï-Bohm Biatougou
Nakougou Moï-Bohm Biatougou
APAudrey Picot
Audrey Picot
MAMyriam Abiou-Mourgues
Myriam Abiou-Mourgues
MBMatthieu Bourdin
Matthieu Bourdin
YRYohann Repesse
Yohann Repesse
RMRichard Macrez
Richard Macrez
BACKGROUND: Ischemic stroke requires effective reperfusion therapies to limit brain injury, yet rtPA (recombinant tissue-type plasminogen activator) efficacy is limited, particularly in platelet-rich thrombi. Neutrophil extracellular traps (NETs) and their components, especially histones and DNA, contribute to thrombolysis resistance. Chondroitin sulfate (CS), a glycosaminoglycan with high affinity for extracellular histones, may neutralize their prothrombotic effects and improve outcomes. This study aimed to evaluate the effects of CS in preclinical ischemic stroke models and its impact on components of neutrophil extracellular traps. METHODS: Two mouse models of middle cerebral artery occlusion were used: a fibrin-rich thromboembolic stroke model (rtPA-sensitive) and a platelet-rich aluminum chloride model (rtPA-resistant). Mice received intravenous CS (30–120 mg/kg), rtPA (10 mg/kg), or a combination of both. Lesion volume, tissue recanalization/reperfusion, hemorrhagic transformation, and functional connectivity were assessed via 7T magnetic resonance imaging and ultrafast Doppler imaging. In vitro coagulation-fibrinolysis assays examined the effects of neutrophil extracellular trap components on fibrin polymerization and fibrinolysis, and their modulation by CS±rtPA. RESULTS: In the fibrin-rich model, CS alone reduced lesion volume by 36% and improved recanalization, comparable to rtPA (43%), without increasing hemorrhagic transformation. CS enhanced functional connectivity recovery at 24 hours, whereas combined CS+rtPA lost these benefits. In the platelet-rich model, CS did not affect lesion size, recanalization, or hemorrhage. In vitro, histones promoted clot stabilization and altered fibrinolysis, effects fully neutralized by equimolar CS in the absence of rtPA. With rtPA, CS’s neutralizing capacity was reduced, and histone-driven profibrinolysis was accentuated at higher CS doses. DNA produced opposite effects to histones, and combined DNA+histones masked histone activity, resisting inhibition by CS+DNase. CONCLUSIONS: CS mitigates histone-mediated prothrombotic effects, improves reperfusion and network recovery in fibrin-rich stroke, but loses efficacy in platelet-rich thrombi and when combined with rtPA. These findings support CS as a potential adjunct or alternative therapy, particularly for patients with contraindications to rtPA.

22 April 2026 in Research Square
Verified
Preprint
Open access
PDF file
MCMartine Cohen-salmon
Martine Cohen-salmon
LLLucie Lemale
Lucie Lemale
MAMyriam Abioui-Mourgues
Myriam Abioui-Mourgues
RARodrigo Alvear-Perez
Rodrigo Alvear-Perez
MRMarina Rubio
Marina Rubio
BDBarbara Delaunay-Piednoir
Barbara Delaunay-Piednoir
The gliovascular unit (GVU), a specialized interface between the brain and the vascular system, assembles and matures after birth and establishes essential homeostatic functions, including blood–brain barrier integrity, metabolic exchanges, fluid drainage, neurovascular coupling, and immune surveillance. Here, we systematically compared the postnatal maturation of the cortical GVU in male vs. female mice. On P15, males exhibited a transiently greater vessel density and a higher level of aquaporin 4 expression in perivascular astrocyte processes. Females exhibited a higher density of perivascular macrophages expressing the lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-1), along with earlier development of arterial vascular smooth muscle cells and greater cerebral blood flow. Transcriptomic profiling during the P5–P120 period revealed sex-specific developmental trajectories within the GVU, with the most prominent differences on P5. Taken as a whole, our results highlight pronounced sex-dependent differences in GVU assembly, GVU maturation, and the development of molecular programs that might influence brain physiology and vulnerability to neurodevelopmental disorders.

8 April 2026
Verified
Thesis
Closed access
MMMyriam Abioui Mourgues
Myriam Abioui Mourgues
L’Accident Vasculaire Cérébral (AVC) ischémique, causé par l’obstruction d’une artère cérébrale, est l’une des principales causes de mortalité et d’invalidité dans le monde. Bien que des traitements comme le rtPA et la thrombectomie mécanique existent, seul un faible pourcentage de patients y a accès. Par ailleurs, malgré l’investissement de la recherche, les difficultés à transposer les résultats des modèles animaux aux essais cliniques humains limitent le développement de nouvelles thérapies. Cette thèse présente un modèle d’AVC chez la souris éveillée visant à améliorer la transposabilité des études précliniques. Grâce à l’imagerie ultrasonore fonctionnelle (fUS) et à l’IRM, ce modèle permet une évaluation en temps réel des paramètres hémodynamiques ainsi qu’une analyse de la récupération fonctionnelle après l’ischémie. Nous proposons également un nouvel outil d’évaluation de la connectivité cérébrale post-AVC, apportant des informations sur la récupération cérébrale et la réponse au traitement. L’efficacité du traitement thrombolytique standard, le rtPA, a été testée, et une approche innovante de traitement ciblé a été explorée. Les résultats soulignent le potentiel de ces approches multimodales et thérapeutiques ciblées pour améliorer la prise en charge des AVC ischémiques, ouvrant la voie à de nouvelles perspectives de recherche translationnelle.